SERAPH BIOSCIENCES, INC.
Developer of real-time pathogen detection systems designed to treat infections at the point of care. The company's systems represent a paradigm shift away from current methods for screening and identification of dangerous bacterial, viral and fungal pathogens, enabling health care providers to effectively eliminate the need for time-consuming.
3
Funding Rounds
$11.7m
Money raised
Overview
Developer of real-time pathogen detection systems designed to treat infections at the point of care. The company's systems represent a paradigm shift away from current methods for screening and identification of dangerous bacterial, viral and fungal pathogens, enabling health care providers to effectively eliminate the need for time-consuming.